Latest & greatest articles for beclomethasone

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on beclomethasone or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on beclomethasone and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for beclomethasone

21. Inhaled beclomethasone versus placebo for chronic asthma.

Inhaled beclomethasone versus placebo for chronic asthma. BACKGROUND: Inhaled beclomethasone diproprionate (BDP) has been, together with inhaled budesonide, the mainstay of anti-inflammatory therapy for asthma for many years. A range of new prophylactic therapies for asthma is becoming available and BDP is now frequently used as the reference treatment against which these newer agents are being compared. OBJECTIVES: The objectives of this review were to: a) Compare the efficacy of BDP

Cochrane2000

22. A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group.

A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group. 9385125 1997 12 04 1997 12 04 2015 11 19 0028-4793 337 23 1997 Dec 04 The New England journal of medicine N. Engl. J. Med. A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group. 1659-65 An inhaled glucocorticoid is currently the medication of choice (...) for long-term control of persistent asthma in children. The role of long-acting beta2-adrenergic-receptor agonists, such as salmeterol, needs to be defined. We conducted a randomized, double-blind, placebo-controlled, parallel-group, one-year study of 241 children (mean [+/-SD] age, 9.3+/-2.4 years) with clinically stable asthma and less than one month of prior glucocorticoid use. We compared inhaled beclomethasone dipropionate (200 microg twice daily) with salmeterol xinafoate (50 microg twice daily

NEJM1997

23. Cough and wheezing from beclomethasone dipropionate aerosol are absent after triamcinolone acetonide.

Cough and wheezing from beclomethasone dipropionate aerosol are absent after triamcinolone acetonide. Cough and wheezing from beclometh... preview & related info | Mendeley E-mail address Password ( ) Remember me …or sign in with Search Main Navigation › Short URL Annals of Internal Medicine ( 1987 ) Volume: 106 , Issue: 5 , Pages: 700-703 PubMed: Available from or Find this paper at: Abstract Study Objective: To test the hypothesis that patients with asthma who develop cough and wheezing after (...) the use of beclomethasone aerosol would have a better tolerance for triamcinolone aerosol. Design: Randomized, double-blinded, crossover trial. Setting: Pulmonary function laboratory. Patients: Volunteer sample of 24 patients attending an asthma clinic who had developed cough, with or without wheezing, after inhaling beclomethasone aerosol. All patients completed the study. Interventions: Aerosols were used in habitual manufacturers' preparations and canisters, but both were administered in three

Annals of Internal Medicine1987

24. Beclomethasone dipropionate enemas for treating inflammatory bowel disease without producing Cushing's syndrome or hypothalamic pituitary adrenal suppression.

Beclomethasone dipropionate enemas for treating inflammatory bowel disease without producing Cushing's syndrome or hypothalamic pituitary adrenal suppression. 6121181 1982 05 27 1982 05 27 2015 06 16 0140-6736 1 8272 1982 Mar 13 Lancet (London, England) Lancet Beclomethasone dipropionate enemas for treating inflammatory bowel disease without producing Cushing's syndrome or hypothalamic pituitary adrenal suppression. 579-83 Since beclomethasone dipropionate (BDP) is a very potent glucocorticoid (...) Trial Journal Article Randomized Controlled Trial England Lancet 2985213R 0140-6736 KGZ1SLC28Z Beclomethasone AIM IM Adult Beclomethasone administration & dosage pharmacology Clinical Trials as Topic Colitis, Ulcerative drug therapy Cushing Syndrome prevention & control Double-Blind Method Enema Female Humans Hypothalamo-Hypophyseal System drug effects Male Pituitary-Adrenal System drug effects Random Allocation 1982 3 13 1982 3 13 0 1 1982 3 13 0 0 ppublish 6121181 S0140-6736(82)91747-0

Lancet1982

25. Combined therapy with salbutamol and beclomethasone inhalers in chronic asthma.

Combined therapy with salbutamol and beclomethasone inhalers in chronic asthma. 78297 1978 08 28 1978 08 28 2015 06 16 0140-6736 2 8080 1978 Jul 08 Lancet (London, England) Lancet Combined therapy with salbutamol and beclomethasone inhalers in chronic asthma. 70-2 A double-blind cross-over trial was carried out to compare the effect of identical placebo with that of salbutamol inhalers used 30 min before inhalation of 100 microgram of beclomethasone dipropionate (B.D.P.) in 18 chronic (...) asthmatics over two consecutive 4-week periods. The salbutamol and B.D.P. combination resulted in a significant improvement in the peak expiratory flow-rate and F.E.V.1, significantly less use of the rescue inhaler, and better control. Clark R A RA Anderson P B PB eng Clinical Trial Comparative Study Journal Article Randomized Controlled Trial England Lancet 2985213R 0140-6736 0 Aerosols 0 Placebos KGZ1SLC28Z Beclomethasone QF8SVZ843E Albuterol AIM IM Adult Aerosols Aged Albuterol administration & dosage

Lancet1978